Rtw Investments, Lp - Dec 31, 2024 SCHEDULE 13G/A Report for SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (SABS)

Filing Manager: Rtw Investments, Lp
Reporting Manager: RTW Investments, LP
Security: SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: SABS
Shares outstanding: 10.3M shares
Disclosed Ownership: 1.02M shares
Ownership: 9.99%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 09:00 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
RTW Investments, LP	9.99%	1.02M	0	1.02M	/s/ Roderick Wong, M.D.	Roderick Wong, M.D., Managing Partner
Roderick Wong, M.D.	9.99%	1.02M	0	1.02M	/s/ Roderick Wong, M.D.	Roderick Wong, M.D.